Characterization of pro-apoptotic effect of liver failure plasma on primary human hepatocytes and its modulation by molecular adsorbent recirculation system therapy

Artificial Organs

Volumn 31, Issue 9, 2007, Pages 732-742

  Saich, Rebecca ^a   Selden, Clare ^a   Rees, Myrddin ^b   Hodgson, Humphrey ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

Author keywords

Albumin dialysis; Apoptosis; Death receptors; Primary human hepatocytes; Toxins

Indexed keywords

CHEMICAL ACTIVATION; DIALYSIS; DISEASE CONTROL; MOLECULES; PATIENT TREATMENT;

ACUTE LIVER FAILURE; ALBUMIN DIALYSIS; APOPTOTIC EFFECTS; CHRONIC LIVER DISEASE; DEATH-RECEPTOR; END-LABELING; LIVER FAILURE; PRIMARY HUMAN HEPATOCYTES; PRO-APOPTOTIC EFFECTS; RECIRCULATION SYSTEMS;

CELL DEATH;

ALBUMIN; CASPASE 3; CASPASE 8;

ADULT; AGED; ALBUMIN DIALYSIS; APOPTOSIS; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HUMAN; LIVER CELL; LIVER FAILURE; MALE; NICK END LABELING; PLASMA; PRIORITY JOURNAL;

EID: 34548118831     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2007.00447.x     Document Type: Article

References (40)

1. Hughes RD. Review of methods to remove protein-bound substances in liver failure. Int J Artif Organs 2002 25 : 911 7.
2. Spengler U, Zachoval R, Gallati H, et al. Serum levels and in situ expression of TNF-alpha and TNF-alpha binding proteins in inflammatory liver diseases. Cytokine 1996 8 : 864 72.
3. Cain K, Freathy C. Liver toxicity and apoptosis: role of TGF-beta1, cytochrome c and the apoptosome. Toxicol Lett 2001 120 : 307 15.
4. Williams R, Hughes RD, Cochrane AM, Ellis WR, Murray-Lyon IM. Studies on plasma cytotoxicity and liver regeneration in fulminant hepatic failure. Ciba Found Symp 1977 55 : 299 305.
5. Newsome PN, Tsiaoussis J, Masson S, et al. Serum from patients with fulminant hepatic failure causes hepatocyte detachment and apoptosis by a b-integrin pathway. Hepatology 2004 40 : 636 45.
6. Anderson C, Thabrew MI, Hughes RD. Assay to detect inhibitory substances in serum of patients with acute liver failure. Int J Artif Organs 1999 22 : 113 7.
7. Hughes RD, Yamada H, Gove CD, Williams R. Inhibitors of hepatic DNA synthesis in fulminant hepatic failure. Dig Dis Sci 1991 36 : 816 9.
8. Anilkumar T, Ryan CJ, Aslam M, Poulsom R, Alison M. The anti-proliferative effect of plasma from rats with acute fulminant hepatic failure. Scand J Gastroenterol 1997 32 : 1152 61.
9. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972 26 : 239 57.
10. Guicciardi ME, Gores GJ. Apoptosis: a mechanism of acute and chronic liver injury. Gut 2005 54 : 1024 33.
11. Kasahara I, Saitoh K, Nakamura K. Apoptosis in acute hepatic failure: histopathological study of human liver tissue using the tunel method and immunohistochemistry. J Med Dent Sci 2000 47 : 167 75.
12. Memon MA, Karademir S, Shen J, et al. Seventh Day Syndrome-acute hepatocyte apoptosis associated with a unique syndrome of graft loss following liver transplantation. Liver 2001 21 : 13 7.
13. Rivero M, Crespo J, Fabrega E, et al. Apoptosis mediated by the Fas system in the fulminant hepatitis by hepatitis B virus. J Viral Hepat 2002 9 : 107 13.
14. Nasir A, Arora HS, Kaiser HE. Apoptosis and pathogenesis of viral hepatitis C - an update. In Vivo 2000 14 : 297 300.
15. Pretet JL, Pelletier L, Bernard B, Coumes-Marquet S, Kantelip B, Mougin C. Apoptosis participates to liver damage in HSV-induced fulminant hepatitis. Apoptosis 2003 8 : 655 63.
16. Strand S, Hofmann WJ, Grambihler A, et al. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat Med 1998 4 : 588 93.
17. Ziol M, Tepper M, Lohez M, et al. Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis. J Hepatol 2001 34 : 254 60.
18. Masuichi H, Seki S, Kitada T, et al. Significant role of apoptosis in type-1 autoimmune hepatitis. Osaka City Med J 1999 45 : 61 79.
19. Sakamoto Y, Nakajima T, Misawa S, et al. Acute liver damage with characteristic apoptotic hepatocytes by ingestion of Aplysia kurodai, a sea hare. Intern Med 1998 37 : 927 9.
20. Ryo K, Kamogawa Y, Ikeda I, et al. Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure. Am J Gastroenterol 2000 95 : 2047 55.
21. Jin Z, El Deiry WS. Overview of cell death signalling pathways. Cancer Biol Ther 2005 4 : 139 63.
22. Taieb J, Mathurin P, Poynard T, Gougerot-Pocidalo MA, Chollet-Martin S. Raised plasma soluble Fas and Fas-ligand in alcoholic liver disease. Lancet 1998 351 : 1930 1.
23. Hayashi N, Mita E. Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis. J Viral Hepat 1999 6 : 357 65.
24. Tagami A, Ohnishi H, Hughes RD. Increased serum soluble Fas in patients with acute liver failure due to paracetamol overdose. Hepato-gastroenterology 2003 50 : 742 5.
25. Tagami A, Ohnishi H, Moriwaki H, Phillips M, Hughes RD. Fas-mediated apoptosis in acute alcoholic hepatitis. Hepato-gastroenterology 2003 50 : 443 8.
26. Rivero M, Crespo J, Mayorga M, Fabrega E, Casafont F, Pons-Romero F. Involvement of the Fas system in liver allograft rejection. Am J Gastroenterol 2002 97 : 1501 6.
27. Mundt B, Kuhnel F, Zender L, et al. Involvement of TRAIL and its receptors in viral hepatitis. FASEB J 2003 17 : 94 6.
28. Tokushige K, Yamaguchi N, Ikeda I, Hashimoto E, Yamauchi K, Hayashi N. Significance of soluble TNF receptor-I in acute-type fulminant hepatitis. Am J Gastroenterol 2000 95 : 2040 6.
29. Sodeman T, Bronk SF, Roberts PJ, Miyoshi H, Gores GJ. Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. Am J Physiol Gastrointest Liver Physiol 2000 278 : G992 9.
30. Di Campli C, Zileri Dal Verme L, Andrisani MC, et al. Advances in extracorporeal detoxification by MARS dialysis in patients with liver failure. Curr Med Chem 2003 10 : 341 8.
31. Kosai K, Matsumoto K, Nagata S, Tsujimoto Y, Nakamura T. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem Biophys Res Commun 1998 244 : 683 90.
32. Schmidt LE, Larsen FS. Prognostic implications of hyperlactatemia, multiple organ failure and systemic inflammatory response syndrome in patients with acetaminophen induced acute liver failure. Crit Care Med 2006 34 : 337 43.
33. Stange J, Hassanein TI, Mehta R, Mitzner SR, Bartlett RH. The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers. Artif Organs 2002 26 : 103 10.
34. Lai WK, Haydon G, Mutimer D, Murphy N. The effect of molecular adsorbent recirculating system on pathophysiological parameters in patients with acute liver failure. Intensive Care Med 2005 31 : 1544 9.
35. Sen S, Davies NA, Mookerjee RP, et al. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transpl 2004 10 : 1109 19.
36. Catalina MV, Barrio J, Anaya F, et al. Hepatic and systemic haemodynamic changes after MARS in patients with acute on chronic liver failure. Liver Int 2003 23 (Suppl. 3 39 43.
37. Di Campli C, Zocco MA, Gaspari R, et al. The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure. Transplant Proc 2005 37 : 2551 3.
38. Contreras JL, Vilatoba M, Eckstein C, et al. Caspase-8 and caspase-3 small interfering RNA decreases ischemia/reperfusion injury to the liver in mice. Surgery 2004 136 : 390 400.
39. Valentino KL, Gutierrez M, Sanchez R, Winship MJ, Shapiro DA. First clinical trial of a novel caspase inhibitor: anti-apoptotic caspase inhibitor, IDN-6556, improves liver enzymes. Int J Clin Pharmacol Ther 2003 41 : 441 9.
40. Moretti S, Famularo G, Marcellini S, et al. L-carnitine reduces lymphocyte apoptosis and oxidant stress in HIV-1-infected subjects treated with zidovudine and didanosine. Antioxid Redox Signal 2002 4 : 391 403.